Detalhe da pesquisa
1.
A European Registry Evaluating Symptomatic Effectiveness of Pharmacologically Treated Patients with Lower Urinary Tract Symptoms due to Benign Prostatic Enlargement: Lessons Learned.
J Urol
; 205(4): 1145-1152, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33259270
2.
Comparison of expected treatment outcomes, obtained using risk models and international guidelines, with observed treatment outcomes in a Dutch cohort of patients with non-muscle-invasive bladder cancer treated with intravesical chemotherapy.
BJU Int
; 114(2): 193-201, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24304638
3.
Results at 1 Year from SATURN, A European, Prospective, Multicenter Registry for Male Stress Urinary Incontinence Surgery.
Eur Urol Focus
; 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38627124
4.
SATURN: A European, Prospective, Multicentre Registry for Male Stress Urinary Incontinence Surgery.
Eur Urol Open Sci
; 57: 91-97, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-38020526
5.
Quality of Life in Patients with High-grade Non-muscle-invasive Bladder Cancer Undergoing Standard Versus Reduced Frequency of Bacillus Calmette-Guérin Instillations: The EAU-RF NIMBUS Trial.
Eur Urol Open Sci
; 56: 15-24, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37822514
6.
Incidence of Nocturia in Men with Lower Urinary Tract Symptoms Associated with Benign Prostatic Enlargement and Outcomes After Medical Treatment: Results from the Evolution European Association of Urology Research Foundation Prospective Multinational Registry.
Eur Urol Focus
; 7(1): 178-185, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31345783
7.
Automated Bone Scan Index as an Imaging Biomarker to Predict Overall Survival in the Zometa European Study/SPCG11.
Eur Urol Oncol
; 4(1): 49-55, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31186177
8.
Treatment of High-grade Non-muscle-invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations: Results of the European Association of Urology Research Foundation Randomised Phase III Clinical Trial "NIMBUS".
Eur Urol
; 78(5): 690-698, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32446864
9.
Adjuvant recMAGE-A3 Immunotherapy After Cystectomy for Muscle-invasive Bladder Cancer: Lessons Learned from the Phase 2 MAGNOLIA Clinical Trial.
Eur Urol Focus
; 5(5): 849-852, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29477797
10.
Reply to Emre Karabay and Ilker Tinay's Letter to the Editor re: Treatment of High-grade Non-muscle-invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations: Results of the European Association of Urology Research Foundation Randomised Phase III Clinical Trial "NIMBUS". Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.04.066.
Eur Urol
; 78(4): e163-e164, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32693930
11.
Prevention of bone metastases in patients with high-risk nonmetastatic prostate cancer treated with zoledronic acid: efficacy and safety results of the Zometa European Study (ZEUS).
Eur Urol
; 67(3): 482-91, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24630685
12.
Intracutaneous and intravesical immunotherapy with keyhole limpet hemocyanin compared with intravesical mitomycin in patients with non-muscle-invasive bladder cancer: results from a prospective randomized phase III trial.
J Clin Oncol
; 30(18): 2273-9, 2012 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-22585689
13.
Smoking status is a risk factor for recurrence after transurethral resection of non-muscle-invasive bladder cancer.
Eur Urol
; 60(4): 713-20, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21794974
14.
Comparison of three schedules of intravesical epirubicin in patients with non-muscle-invasive bladder cancer.
Eur Urol
; 53(5): 984-91, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18248876